Code & Co.

  • epiNET logo
  • Extra logo for case study

Engagement — Add-on Due Diligence

Code & Co. advised medavis GmbH, a portfolio company of funds advised by Bregal Unternehmerkapital, ahead of the investment in epiNET GmbH, a leading software provider for hygiene management in the DACH region.

epiNET is a leading software provider for hygiene management in the DACH region, providing solutions to over 700 hospitals and 150+ laboratories. Code & Co. provided Tech & Product Due Diligence to medavis, a Bregal portfolio company.

epiNET have a suite of products, for example: HyBASE, epiNET’s flagship offering is a statistics, analysis, and documentation system for modern microbiology, epidemiology, and hospital hygiene management. HyTEC, a LIMS for hygiene and water laboratories, supports its users with the organization and administration of hygiene processes and hygiene technology.

Scope of Work

Code & Co. provided Tech & Product Due Diligence to Medavis, a portfolio company of Bregal Unternehmerkapital. Code & Co. performed a thorough assessment of epiNET’s range of products evaluating the architecture, tech stack, and foundational engineering processes of each product. Furthermore, we assessed epiNET's operational capabilities, customer support effectiveness, and the alignment of their product roadmap with strategic goals.

About epiNET

epiNET is a founder-managed medium-sized company that offers a broad range of hygiene management software solutions to hospitals, laboratories, and AMR networks. With over 700 hospitals and labs as customers, epiNET is the leading provider of hygiene management solutions in the DACH region. epiNET’s solutions focus on the structuring of microbiological findings that can be used in daily laboratory and clinical operations for monitoring, evaluation and documentation purposes as well as for epidemiological surveillance.

About Bregal Unternehmerkapital

Bregal Unternehmerkapital (“BU”) is part of a family-owned business that has grown over several generations. Funds advised by BU invest in European mid-sized companies across a wide range of sectors with a focus on market leaders and “hidden champions” with strong management teams and outbreak potential. With patient capital, entrepreneurial expertise, and a partnership approach, Bregal works closely with entrepreneurs to develop, internationalize and digitalize portfolio companies, and to help them generate sustainable value on a responsible basis.

As part of its comprehensive commitment to ESG, BU also supports existing portfolio companies with loans at attractive terms to finance sustainability investments provided by Bregal’s dedicated EUR 40 million Sustainable Development Fund and, in 2020, with grants for charitable projects to contribute to portfolio companies’ pandemic responses provided by Bregal’s EUR 3 million COVID-19 relief fund. Furthermore, in 2021, BU committed to ambitious science-based climate targets for 2030 as part of its commitment to decarbonize its portfolio and achieve net-zero.

For more information, please visit and find Bregal Unternehmerkapital on LinkedIn.

About Medavis

Medavis GmbH is a specialist for process optimization in radiology and offers software solutions that ensure stability, reliability, and performance. With workflow solutions from medavis, radiologists ensure a fast, secure, and digital flow of information and sustainably increase the efficiency of patient care.